跳至主要内容
临床试验/ISRCTN32956054
ISRCTN32956054已完成未知

Assessment of cost-effectiveness of the treatment of varicose veins

Department of Health (UK)0 个研究点目标入组 1,009 人开始时间: 2003年4月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
1,009

研究概览

简要总结

2006 Results article in http://www.ncbi.nlm.nih.gov/pubmed/16707070 HTA monograph

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Patients undergoing treatment for varicose veins

排除标准

  • Added as of 25/07/2007:
  • General exclusion criteria:
  • 1. Unwillingness to give informed consent
  • 2. Unwilling or unable to complete assessment protocol
  • 3. Current evidence of thrombophlebitis, ulceration or DVT
  • Specific exclusion criteria:
  • Group 1 Sclerotherapy vs conservative treatment:
  • 1. Patients with deep venous insufficiency confirmed by duplex
  • 2. Allergy to sclerosant
  • 3. Diameter of varicose veins >2 cm
  • Group 2 Sclerotherapy vs surgery:
  • 1. Patients with deep venous insufficiency confirmed by duplex
  • 2. Allergy to sclerosant
  • 3. Diameter of varicose veins >2 cm
  • 4. Pre-existing co-morbidities that would make them unsuitable for surgery
  • 5. BMI >32
  • Group 3 Surgery vs conservative treatment:
  • 1. Patients with deep venous insufficiency confirmed by duplex
  • 2. Allergy to sclerosant
  • 3. Diameter of varicose veins >2 cm
  • 4. Pre-existing co-morbidities that would make them unsuitable for surgery.
  • 5. BMI >32

研究者

发起方
Department of Health (UK)

相似试验

Assessment of cost-effectiveness of the treatment of... | 临床试验